Sterling Capital Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.98K | Buy |
266
+163
| +158% | +$2.44K | ﹤0.01% | 2632 |
|
|
2025
Q1 | $1.21K | Sell |
103
-68
| -40% | -$796 | ﹤0.01% | 2754 |
|
|
2024
Q4 | $3.91K | Buy |
171
+149
| +677% | +$3.41K | ﹤0.01% | 2563 |
|
|
2024
Q3 | $923 | Buy |
+22
| New | +$923 | ﹤0.01% | 2576 |
|
|
2015
Q2 | – | Sell |
-650
| Closed | -$107K | – | 913 |
|
|
2015
Q1 | $107K | Hold |
650
| – | – | ﹤0.01% | 856 |
|
|
2014
Q4 | $97K | Sell |
650
-86
| -12% | -$12.8K | ﹤0.01% | 899 |
|
|
2014
Q3 | $98K | Hold |
736
| – | – | ﹤0.01% | 882 |
|
|
2014
Q2 | $139K | Sell |
736
-442
| -38% | -$83.5K | ﹤0.01% | 865 |
|
|
2014
Q1 | $300K | Buy |
+1,178
| New | +$300K | ﹤0.01% | 860 |
|